Polomar Health Services PMHS
OTC PMHS
$0.17 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT

Polomar Health Services (PMHS) Current Deferred Revenue (2025 - 2026)

Updated

Polomar Health Services (PMHS) recorded Current Deferred Revenue of $300,000 in Q2 2026.

Analysis

Polomar Health Services (PMHS) Current Deferred Revenue (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Polomar Health Services 4.81 Mn 4.37 Mn 935,916.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 300,000.00
Dec 31, 2025 300,000.00
API Access

Polomar Health Services Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=PMHS&period=max&api_key=YOUR_API_KEY